Search Results "#Inhibitors"

Blogs

arrow_forward View More Results
Fusion Inhibitors Market to Surpass US$ 7.2 Billion by 2031 Amid Rising HIV Burden and Advancements in Antiviral Drug Development
Posted by Mayur on July 27 2026 at 01:19 PM   public
The global fusion inhibitors market is witnessing remarkable growth, fueled by the increasing prevalence of viral infections, particularly Human Immunodeficiency Virus (HIV) and Acquired Immunode...
MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
Posted by Surbhi on July 10 2026 at 05:32 PM   public
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringW...
Immune Checkpoint Inhibitors Market Trends, Opportunities, and Forecast (2025–2030)
Posted by jameswilliamsus on November 06 2025 at 01:47 PM   public
As per MarkNtel Advisors the Immune Checkpoint Inhibitor Market size was valued at around USD 51.2 billion in 2023 and is projected to grow at a CAGR of 15.6% during the forecast period of 2025-3...
SGLT2 Inhibitors Market Outlook 2030: Leading Companies & Growth Insights
Posted by john ryan on October 30 2025 at 02:16 PM   public
Future SGLT2 Inhibitors Market: Key Dynamics, Size & Share Analysis The Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34...
Liver Fibrosis IL Inhibitors Market Expands on Back of Advancements in Anti-Fibrotic Therapies
Posted by sia smith on July 19 2025 at 05:23 PM   public
"Executive Summary Liver Fibrosis Interleukin (Il) Inhibitors Market : CAGR Value The global liver fibrosis interleukin (Il) inhibitors market was valued at USD 776.62 million in 2024 and is ex...
arrow_forward